Patents by Inventor Guenter Mayer
Guenter Mayer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240140978Abstract: Methods and compositions are provided for oligonucleotides that bind targets of interest. The targets include cells and microvesicles, such as those derived from various diseases. The oligonucleotides can be used for diagnostic and therapeutic purposes. The target of the oligonucleotides can be a target such as PARP1, HIST1H1B, HIST1H1D, NCL, FBL, SFPQ, RPL12, ACTB, HIST1H4A, SSBP1, NONO, H2AFJ, and DDX21, or a complex, subunit or fragment thereof.Type: ApplicationFiled: June 30, 2023Publication date: May 2, 2024Inventors: Heather O`Neill, Günter Mayer, Mark Miglarese, David Spetzler
-
Patent number: 11940112Abstract: An automotive solid-state headlamp includes a lamp body extending in a longitudinal direction, the lamp body having a rear base portion and a front portion and including a support member and a light-transmissive housing, a plurality of solid-state light sources arranged on the support member at the rear base portion of the lamp body, a drive circuitry electrically coupled to the light sources and arranged at the rear base portion of the lamp body and configured to operate the plurality of light sources when energized and reflector optics arranged at the front portion, wherein the solid-state light sources are configured to emit light towards the reflector optics, the reflector optics including a first reflector optic portion and a second reflector optic portion and wherein each of a plurality of first reflective surfaces disposed on the first reflector optic portion extend in an annular region around the longitudinal direction from the plurality of solid-state light sources towards the first reflector optic pType: GrantFiled: March 22, 2021Date of Patent: March 26, 2024Assignee: OSRAM GmbHInventors: Christian Seichter, Kevin Bayer, Hans Guenter Mayer, Ralf Lindner
-
Publication number: 20240076680Abstract: The present invention relates to an aptamer not binding to the receptor-binding domain of the SARS-CoV-2 spike glycoprotein nor inhibiting the interaction of the receptor-binding domain (RED) of spike glycoprotein with angiotensin-converting enzyme II (ACE2) and/or comprising or consisting of a nucleotide sequence SEQ ID NO: 1, a composition comprising the aptamer, and the use of the aptamer in the detection of SARS-CoV-2 or diagnosis or treatment of a SARS-CoV-2 infection.Type: ApplicationFiled: December 12, 2021Publication date: March 7, 2024Applicant: RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONNInventors: Günter MAYER, Michael FAMULOK, Anton SCHMITZ, Anna Maria WEBER, Stefan BREUERS, Volkmar FIEBERG
-
Publication number: 20230358760Abstract: The present invention relates to an aptamer comprising a nucleotide sequence SEQ ID NO: 1, preferably comprising or consisting of a nucleotide sequence SEQ ID NO: 4-6. The invention further relates to a composition comprising the aptamer, and the use of the aptamer as a medicament or a diagnostic reagent, particularly for use in the detection or diagnosing of a rejection of a renal allograft.Type: ApplicationFiled: August 31, 2021Publication date: November 9, 2023Applicants: RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONN, LEIBNIZ UNIVERSITÄT HANNOVERInventors: Günter MAYER, Julia SIEGL, Cornelia BLUME, Linh PHUNG
-
Patent number: 11761601Abstract: In an embodiment an automotive solid-state headlamp includes a lamp body extending in a longitudinal direction, the lamp body having a rear base portion and a front portion and including a support member disposed in a light-transmissive housing, a plurality of solid-state light sources arranged on the support member at the rear base portion of the lamp body, and a drive circuitry electrically coupled to the light sources and arranged at the rear base portion of the lamp body and configured to operate the plurality of light sources when energized, wherein the plurality of light sources, when energized, are configured to cause the solid-state lamp to emit, through the light-transmissive housing (a) a luminous flux of at least 1500 lumens +/?10% when energized with a 13.2 Volt test voltage, or of at least 1750 lumens +/?10% when energized with a 28 Volt test voltage, or (b) a luminous flux of at least 1350 lumens +/?10% when energized with a 13.Type: GrantFiled: March 22, 2021Date of Patent: September 19, 2023Assignee: OSRAM GmbHInventors: Christian Seichter, Kevin Bayer, Hans Guenter Mayer, Ralf Lindner
-
Patent number: 11725023Abstract: Methods and compositions are provided for oligonucleotides that bind targets of interest. The targets include cells and microvesicles, such as those derived from various diseases. The oligonucleotides can be used for diagnostic and therapeutic purposes. The target of the oligonucleotides can be a target such as PARP1, HIST1H1B, HIST1H1D, NCL, FBL, SFPQ, RPL12, ACTB, HIST1H4A, SSBP1, NONO, H2AFJ, and DDX21, or a complex, subunit or fragment thereof.Type: GrantFiled: February 3, 2021Date of Patent: August 15, 2023Assignee: Caris Science, Inc.Inventors: Heather O'Neill, Günter Mayer, Mark Miglarese, David Spetzler
-
Publication number: 20230194064Abstract: In an embodiment a reflector optical system includes a reflector body having a rotational symmetry about a longitudinal axis and including a first reflector optic portion having a substantially concave shape and a second reflector optic portion extending along the longitudinal axis, the first reflector optic portion facing the second reflector optic portion, wherein the first reflector optic portion includes a plurality of first reflective surfaces and the second reflector optic portion includes a plurality of second reflective surfaces in spaced light-receiving relation to the plurality of first reflective surfaces.Type: ApplicationFiled: March 22, 2021Publication date: June 22, 2023Inventors: Christian Seichter, Kevin Bayer, Hans Guenter Mayer, Ralf Lindner
-
Publication number: 20220356203Abstract: Methods and compositions are provided for oligonucleotides that bind targets of interest. The targets include cells and microvesicles, such as those derived from various diseases. The oligonucleotides can be used for diagnostic and therapeutic purposes. The target of the oligonucleotides can be a target such as PARP1, HIST1H1B, HIST1H1D, NCL, FBL, SFPQ, RPL12, ACTB, HIST1H4A, SSBP1, NONO, H2AFJ, and DDX21, or a complex, subunit or fragment thereof.Type: ApplicationFiled: February 3, 2021Publication date: November 10, 2022Inventors: Heather O`Neill, Günter Mayer, Mark Miglarese, David Spetzler
-
Publication number: 20220073921Abstract: The present invention relates to an aptamer comprising a nucleotide sequence SEQ ID NO: 1 or a fragment thereof of at least 20 contiguous nucleotides of the nucleotide sequence SEQ ID NO: 2, wherein the aptamer comprises a polyethylene glycol (PEG) moiety conjugated to the 5? or the 3? end. The invention further relates to a composition comprising the aptamer, and the use of the aptamer in the diagnosis and treatment of cancer, particularly hormone refractory prostate tumours.Type: ApplicationFiled: January 20, 2020Publication date: March 10, 2022Applicant: RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONNInventors: Frédéric DUCONGÉ, Andreas LINGNAU, Holger WEBER, Michael KUBBUTAT, Günter MAYER
-
Publication number: 20210310004Abstract: The invention relates to a method of identifying or producing an aptamer, the method comprising the steps of: a) Providing a candidate mixture of nucleic acids; b) Contacting the candidate mixture with a target sample; c) Partitioning nucleic acids that bind to the target sample from those that do not bind; d) Amplifying the binding nucleic acids to produce a population of nucleic acids that bind the target sample; e) Single strand displacement of the amplified nucleic acids, f) optionally repeating the steps a) to e), thereby identifying or producing an aptamer, wherein the target sample provides one or more peptides and/or proteins in a denatured form.Type: ApplicationFiled: July 29, 2019Publication date: October 7, 2021Applicant: RHEINISCHE FRIEDRICH-WILHELMS-UNIVERSITÄT BONNInventors: Günter MAYER, Nora KARNOWSKI, Maren HAMANN, Tjasa LEGEN
-
Patent number: 10941176Abstract: Methods and compositions are provided for oligonucleotides that bind targets of interest. The targets include cells and microvesicles, such as those derived from various diseases. The oligonucleotides can be used for diagnostic and therapeutic purposes. The target of the oligonucleotides can be a target such as PARP1, HIST1H1B, HIST1H1D, NCL, FBL, SFPQ, RPL12, ACTB, HIST1H4A, SSBP1, NONO, H2AFJ, and DDX21, or a complex, subunit or fragment thereof.Type: GrantFiled: July 28, 2016Date of Patent: March 9, 2021Assignee: Caris Science, Inc.Inventors: Heather O'Neill, Günter Mayer, Mark Miglarese, David Spetzler
-
Publication number: 20190359983Abstract: Methods and compositions are provided for oligonucleotides that bind targets of interest. The targets include cells and microvesicles, such as those derived from various diseases. The oligonucleotides can be used for diagnostic and therapeutic purposes. The target of the oligonucleotides can be a member of a ribonucleoprotein or spliceosomal complex such heterologous nuclear ribonucleoprotein U (hnRNP U).Type: ApplicationFiled: February 2, 2018Publication date: November 28, 2019Inventors: Heather O'Neill, Günter Mayer, Sonal Tonapi, Vaishali Pannu, Mark Miglarese, David Spetzler
-
Publication number: 20190256546Abstract: Methods and compositions are provided for oligonucleotides that bind targets of interest. The targets include cells and microvesicles, such as those derived from various diseases. The oligonucleotides can be used for diagnostic and therapeutic purposes. The target of the oligonucleotides can be a target such as PARP1, HIST1H1B, HIST1H1D, NCL, FBL, SFPQ, RPL12, ACTB, HIST1H4A, SSBP1, NONO, H2AFJ, and DDX21, or a complex, subunit or fragment thereof.Type: ApplicationFiled: July 28, 2016Publication date: August 22, 2019Inventors: Heather O'Neill, Günter Mayer, Mark Miglarese, David Spetzler
-
Patent number: 9939443Abstract: Methods are provided for selecting aptamers that are specific to a target of interest from amongst a library of potential aptamer sequences. Aptamers disclosed can be used to detect and/or characterize biological entities of interest, e.g. microvesicles and/or surface antigens. Further disclosed are biomarkers that can be used for diagnosing different disorders including different types of cancer.Type: GrantFiled: December 19, 2013Date of Patent: April 10, 2018Assignee: Caris Life Sciences Switzerland Holdings GmbHInventors: David Spetzler, Valeriy Domenyuk, Tassilo Hornung, Günter Mayer, Michael Famulok
-
Publication number: 20170298343Abstract: The invention relates to a method of identifying or producing an aptamer, and a reagent comprising a nucleic acid ligand capable of binding a target sample, wherein the nucleic acid ligand comprises at least one nucleobase modified to contain an azide-alkyne chemical group.Type: ApplicationFiled: September 30, 2015Publication date: October 19, 2017Inventors: Guenter Mayer, Fabian Tolle
-
Patent number: 9790507Abstract: The present invention relates to an aptamer comprising a nucleotide sequence SEQ ID NO: 1, a composition comprising an aptamer, and the use of the aptamer in the diagnosis and treatment of cancer, particularly solid tumors.Type: GrantFiled: May 26, 2014Date of Patent: October 17, 2017Assignee: RHEINISCHE FRIEDRICH-WILHELMS UNIVERSITÄT BONNInventors: Günter Mayer, Ursula Maria Katia Schöler, Mohammad Seyed Taghdisi Heidarian
-
Publication number: 20160152981Abstract: The present invention relates to an aptamer comprising a nucleotide sequence SEQ ID NO: 1, a composition comprising an aptamer, and the use of the aptamer in the diagnosis and treatment of cancer, particularly solid tumoursType: ApplicationFiled: May 26, 2014Publication date: June 2, 2016Inventors: Günter Mayer, Ursula Maria Katia Schöler, Mohammad Seyed Taghdisi Heidarian
-
Publication number: 20160069889Abstract: Methods are provided for selecting aptamers that are specific to a target of interest from amongst a library of potential aptamer sequences. Aptamers disclosed can be used to detect and/or characterize biological entities of interest, e.g. microvesicles and/or surface antigens. Further disclosed are biomarkers that can be used for diagnosing different disorders including different types of cancer.Type: ApplicationFiled: December 19, 2013Publication date: March 10, 2016Inventors: David SPETZLER, Valeriy DOMENYUK, Tassilo HORNUNG, Günter MAYER, Michael FAMULOK
-
Patent number: 8846645Abstract: The present invention relates to compounds according to general formula (I), pharmaceutical compositions comprising compounds according to general formula (I) and the use of the compounds for the treatment of a bacterial infection, particularly for use as an antibiotic.Type: GrantFiled: December 13, 2011Date of Patent: September 30, 2014Assignees: Rheinische Friedrich-Wilhelms Universität Bonn, Universität KonstanzInventors: Günter Mayer, Christina Elsbeth Luense, Valentin Wittmann, Magnus S. Schmidt
-
Patent number: 8667697Abstract: The invention relates to an eccentric gear arrangement of a motor-driven, hand-guided hedge trimmer (1). The eccentric gear arrangement includes two shearing blades (2, 3) driven in mutually opposite directions over a displacement path (a). Each shearing blade has a connecting link (4, 5) as well as an eccentric wheel (6) having a drive wheel (7) and two eccentrics (8, 9). The eccentric wheel (6) rotates about a rotational axis (10). The two connecting links (4, 5) lie directly above one another. The two eccentrics (8, 9) are arranged on the same side of the drive wheel (7) and engage each in one of the two connecting links (4, 5). The two shearing blades (2, 3) have contact pressure surfaces (11, 12) in the region of their two connecting links (4, 5) and are offset with respect to each other in such a manner that they are exposed at least over a portion of the displacement path (a). Two downholders (13, 14) are provided which act each on one of the assigned contact pressure surfaces (11, 12).Type: GrantFiled: January 28, 2011Date of Patent: March 11, 2014Assignee: Andreas Stihl AG & Co. KGInventors: Markus Hittmann, Ralf Schenk, Reinhard Friedrich, Günter Mayer